How are DXCM butterfly max profit and max loss calculated?

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the DXCM butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 40.94%), the computed maximum profit is $263.93 per contract and the computed maximum loss is -$122.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a DXCM butterfly?

The breakeven for the DXCM butterfly priced on this page is roughly $59.23 and $64.78 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DXCM market-implied 1-standard-deviation expected move is approximately 11.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current DXCM implied volatility affect this butterfly?

DXCM ATM IV is at 40.94% with IV rank near 25.17%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

DXCM Butterfly Strategy

DXCM (DexCom, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators.

DXCM (DexCom, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $22.60B, a trailing P/E of 24.24, a beta of 1.40 versus the broader market, a 52-week range of 54.11-89.98, average daily share volume of 4.5M, a public-listing history dating back to 2005, approximately 10K full-time employees. These structural characteristics shape how DXCM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.40 indicates DXCM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a butterfly on DXCM?

A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.

Current DXCM snapshot

As of May 15, 2026, spot at $61.55, ATM IV 40.94%, IV rank 25.17%, expected move 11.74%. The butterfly on DXCM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this butterfly structure on DXCM specifically: DXCM IV at 40.94% is on the cheap side of its 1-year range, which favors premium-buying structures like a DXCM butterfly, with a market-implied 1-standard-deviation move of approximately 11.74% (roughly $7.22 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DXCM expiries trade a higher absolute premium for lower per-day decay. Position sizing on DXCM should anchor to the underlying notional of $61.55 per share and to the trader's directional view on DXCM stock.

DXCM butterfly setup

The DXCM butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DXCM near $61.55, the first option leg uses a $58.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DXCM chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DXCM shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$58.00	$4.80
Sell 2	Call	$62.00	$2.53
Buy 1	Call	$65.00	$1.48

DXCM butterfly risk and reward

Net Premium / Debit: -$122.50
Max Profit (per contract): $263.93
Max Loss (per contract): -$122.50
Breakeven(s): $59.23, $64.78
Risk / Reward Ratio: 2.155

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.

DXCM butterfly payoff curve

Modeled P&L at expiration across a range of underlying prices for the butterfly on DXCM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$122.50
$13.62	-77.9%	-$122.50
$27.23	-55.8%	-$122.50
$40.83	-33.7%	-$122.50
$54.44	-11.5%	-$122.50
$68.05	+10.6%	-$22.50
$81.66	+32.7%	-$22.50
$95.27	+54.8%	-$22.50
$108.87	+76.9%	-$22.50
$122.48	+99.0%	-$22.50

When traders use butterfly on DXCM

Butterflies on DXCM are pinning bets - traders use them when they expect DXCM to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.

DXCM thesis for this butterfly

The market-implied 1-standard-deviation range for DXCM extends from approximately $54.33 on the downside to $68.77 on the upside. A DXCM long call butterfly is a pinning play: it pays maximum at the middle strike if DXCM settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current DXCM IV rank near 25.17% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DXCM at 40.94%. As a Healthcare name, DXCM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DXCM-specific events.

DXCM butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DXCM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DXCM alongside the broader basket even when DXCM-specific fundamentals are unchanged. Always rebuild the position from current DXCM chain quotes before placing a trade.

Frequently asked questions

What is a butterfly on DXCM?: A butterfly on DXCM is the butterfly strategy applied to DXCM (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With DXCM stock trading near $61.55, the strikes shown on this page are snapped to the nearest listed DXCM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are DXCM butterfly max profit and max loss calculated?: Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the DXCM butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 40.94%), the computed maximum profit is $263.93 per contract and the computed maximum loss is -$122.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a DXCM butterfly?: The breakeven for the DXCM butterfly priced on this page is roughly $59.23 and $64.78 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DXCM market-implied 1-standard-deviation expected move is approximately 11.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a butterfly on DXCM?: Butterflies on DXCM are pinning bets - traders use them when they expect DXCM to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
How does current DXCM implied volatility affect this butterfly?: DXCM ATM IV is at 40.94% with IV rank near 25.17%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.